Clinical trial Recruiting at 1 site Interventional Ages 40 to 69

Association Between Severe Periodontitis and Arterial Stiffness: The PAROCAR Study

Official title: Evaluation of the Association Between the Effects of Generalized Stage 3 and 4 Periodontitis on Arterial Stiffness and Cardiovascular Risk: the PAROCAR Study

Run by Nantes University Hospital · NCT07263113 · Data updated 2026-11-12

This study tests whether adults with generalized stage 3-4 periodontitis have greater arterial stiffness than healthy adults, to see if severe gum disease links to higher cardiovascular risk.

Quick facts

Study typeInterventional
Ages40 Years to 69 Years
SexAll
Enrollment206 (estimated)
SponsorNantes University Hospital
Academic / other
Locations1 site (Nantes)
StatusRecruiting
StartedApril 10, 2026
Main results expectedDecember 1, 2027
Study endsDecember 1, 2027
Registry record updatedJune 23, 2026
Trial IDNCT07263113 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40-69 with at least 12 teeth, including those with generalized stage 3-4 periodontitis according to the 2017 Chicago Classification.

Probably not a fit

Individuals with diabetes, hypertension, major cardiovascular disease, BMI ≥ 30, or recent periodontal treatment may not experience direct benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

PAROCAR is a monocentric, prospective cross-sectional study that compares arterial stiffness, measured by pulse wave velocity, between adults with generalized periodontitis stage 3-4 and matched controls without periodontitis. The study enrolls 206 participants aged 40-69, excluding those with diabetes, hypertension, major cardiovascular disease, high BMI, or recent periodontal treatment, among other criteria. Periodontal examinations and PWV measurements are performed to explore potential associations with conventional cardiovascular risk factors. The investigation aims to provide proof of concept for a contributory role of severe periodontitis in cardiovascular risk. Findings may inform future strategies linking oral health and cardiovascular health.

Why it matters

Potential benefit: If successful, the study could support screening and management of periodontal disease as part of cardiovascular risk assessment.

How similar studies have gone: Previous research has suggested links between periodontal inflammation and cardiovascular risk, but this study provides a targeted, cross-sectional assessment of arterial stiffness in a defined severe periodontitis population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 40-69 years
* Minimum of 12 teeth (3 per quadrant)
* Written informed consent Exposed group: generalized periodontitis stage 3 or 4 (Chicago 2017 Classification) Non-exposed group: healthy periodontium

Exclusion Criteria:

* Patients diagnosed with diabetes,
* Patients diagnosed with hypertension or with a history of severe cardiovascular disease,
* Patients diagnosed with familial hypercholesterolaemia,
* Patients with a medical history or current condition that, in the investigator's opinion, is likely to interfere with the study results,
* Patients with a BMI ≥ 30 kg/m²,
* Patients who have previously undergone periodontal treatment,
* Patients who consume more than 2 units of alcohol per day,
* Patients who refuse to participate in the study,
* Minors and patients under the age of 40,
* Adult patients under legal protection (guardianship, curatorship),
* Patients deprived of their liberty,
* Pregnant or breastfeeding women,
* Patients not affiliated with a health insurance scheme (AME)
* Patients already included in another interventional study

Where it's running

  • CHU de Nantes
    Nantes, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.